Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | Targeting the asymptomatic: the DIAN-TU trial

Tammie Benzinger • 8 Sep 2017
AAIC 2017
Alzheimer’s Disease
DIAN-TU

Tammie Benzinger, MD, PhD from Washington University in St. Louis School of Medicine, St. Louis, MO speaks to us about DIAN-TU (NCT01760005), a clinical trial which targets patients of dominantly inherited Alzheimer’s disease who are asymptomatic. Dr Benzinger explains the methodology of the trial, its goals and the future work that is planned. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK.

More from Tammie Benzinger

The role of tau in autosomal dominant Alzheimer’s disease
6:32
The role of tau in autosomal dominant Alzheimer’s disease
Tammie Benzinger • 8 Sep 2017
Longitudinal approaches to Alzheimer’s studies
1:55
Longitudinal approaches to Alzheimer’s studies
Tammie Benzinger • 4 Sep 2017
AAIC 2017: bringing specialists together
0:42
AAIC 2017: bringing specialists together
Tammie Benzinger • 4 Sep 2017
Where are our imaging techniques lacking?
1:11
Where are our imaging techniques lacking?
Tammie Benzinger • 4 Sep 2017

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals